Drug Type Small molecule drug |
Synonyms Flestolol, Flestolol sulfate (USAN), ACC 9089 + [1] |
Target |
Action antagonists |
Mechanism β-adrenoceptors antagonists(Beta adrenergic receptors antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC15H24FN3O8S |
InChIKeyQLCLNERFMKNCBZ-UHFFFAOYSA-N |
CAS Registry88844-73-9 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D04190 | Flestolol Sulfate | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Myocardial Ischemia | Phase 3 | United States | - | |
| Arrhythmias, Cardiac | Phase 1 | Germany | - | - |
| Arrhythmias, Cardiac | Phase 1 | - | - | |
| Heart Failure | Preclinical | United States | 01 May 2002 |





